~~<i id='53E1242EB4'><strike id='53E1242EB4'><tt id='53E1242EB4'><pre id='53E1242EB4'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

fashion

author：Wikipedia 2025-09-28 02:29:39 - browse：1553

Three sales executives, all of them women, have filed suit against Grail, a cancer diagnostics company, alleging that they were harassed, that the company failed to take corrective action, and that it retaliated by removing them from consideration for promotions.

The suits, which were filed earlier this week, are complicated by the fact that Grail was purchased by Illumina, the largest DNA sequencing firm, for $8 billion in 2021 — yet Illumina has left Grail to operate as a separate company. Illumina is named in the suit.

All three plaintiffs are being represented by the Vora Law Firm, based in Santa Monica, Calif.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

explore

hotspot

entertainment

Wikipedia

hotspot

focus

AlexHogan/STATAlothappensinthefirstmonthofhumanembryodevelopmentasasinglecellmorphsintomultitudes.Ye

WSS

Biden's 'march

Harvard's David Sinclair gets blowback over aging

Ukraine and a new approach to mental health in war

Experts study whether long Covid risk adds up with each reinfection

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Stem cell biologist probes earliest stages of human development

knowledge

fashion

explore

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Experts study whether long Covid risk adds up with each reinfection

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Longer MASH drug regimen improved liver, Akero study finds

In age of alternative facts, a scholarly course on calling out crap

Biotech stock slump in 2023: awaiting the turnaround

Virginia high school admissions case could be legal follow

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Duchenne breakthrough therapy leaves behind pioneering families

Change Healthcare: What is it, why does its cyberattack matter?

hotspot

Pregnant women don't need prenatal multivitamins, study concludes

The public health thinking behind the CDC’s new Covid guidance

Lack of health data on LGBTQ+ people has serious consequences

Hearing on Medicare drug price negotiation gets unusually heated

Changes to biosimilar regulatory framework must prioritize patients

Fetal cell organoids grown from amniotic fluid, study finds

entertainment

Wikipedia

hotspot

focus